Pharmaceutical news | ELSI Avocats

Filter by

Pharmaceutical law

Liberal practice contracts, royalties and a framework for benefits, clarifications from the Versailles Court of Appeal ruling of February 27, 2025

The Court confirms the validity of the royalty and the legitimacy of collecting royalties in return for services.

Pharmaceutical law

Ranking of pharma firms: ELSI Avocats wins the Palmarès du Droit 2025 award

ELSI Avocats wins first place in the Palmarès du Droit 2025 in the Health category!

Pharmaceutical law

End of early access authorization and continuity of treatment

The interministerial information note of February 5, 2025 on the end of the AAP specifies the conditions of assumption of responsibility and their information procedures.

Medical device law

Marketing a non-CE-marked medical device: what are the conditions?

A medical device that is not CE-marked can be marketed under certain conditions, via a specific derogation.

Pharmaceutical law

Ranking of Life Sciences law firms: ELSI Avocats at the Legal Summit

New award for ELSI Avocats: best up-and-coming team in the healthcare pharma regulatory category

Pharmaceutical law

Physician influencer: the 10 principles of a responsible content creator according to the Conseil national de l'ordre des médecins (French medical association)

Deciphering the provisions of the content-creating doctor's charter

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Newsletter subscription

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

NEWS

Liberal practice contracts, royalties and a framework for benefits, clarifications from the Versailles Court of Appeal ruling of February 27, 2025

Liberal practice contracts, royalties and a framework for benefits, clarifications from the Versailles Court of Appeal ruling of February 27, 2025

Ranking of pharma firms: ELSI Avocats wins the Palmarès du Droit 2025 award

End of early access authorization and continuity of treatment

Marketing a non-CE-marked medical device: what are the conditions?

Ranking of Life Sciences law firms: ELSI Avocats at the Legal Summit

Physician influencer: the 10 principles of a responsible content creator according to the Conseil national de l'ordre des médecins (French medical association)

Amiodarone, the Court of Cassation sanctions the lack of information in the package insert and engages the responsibility of the laboratory

Cannabis: regulation of the marketing of CBD flower before the Constitutional Council

Certificate of free sale and medical devices

Ranking of Life Sciences law firms: ELSI Avocats at the Legal Summit

Ranking of Life sciences law firms: ELSI Avocats wins 1st place in the Palmarès du Droit 2023

NEWS

Liberal practice contracts, royalties and a framework for benefits, clarifications from the Versailles Court of Appeal ruling of February 27, 2025

Liberal practice contracts, royalties and a framework for benefits, clarifications from the Versailles Court of Appeal ruling of February 27, 2025

Ranking of pharma firms: ELSI Avocats wins the Palmarès du Droit 2025 award

End of early access authorization and continuity of treatment

Marketing a non-CE-marked medical device: what are the conditions?

Ranking of Life Sciences law firms: ELSI Avocats at the Legal Summit

Physician influencer: the 10 principles of a responsible content creator according to the Conseil national de l'ordre des médecins (French medical association)

Amiodarone, the Court of Cassation sanctions the lack of information in the package insert and engages the responsibility of the laboratory

Cannabis: regulation of the marketing of CBD flower before the Constitutional Council

Certificate of free sale and medical devices

Ranking of Life Sciences law firms: ELSI Avocats at the Legal Summit

Ranking of Life sciences law firms: ELSI Avocats wins 1st place in the Palmarès du Droit 2023

SUBSCRIBE TO OUR NEWSLETTER!